Neuroendocrine Tumors: Symptoms, Causes, Stages & Treatment

Neuroendocrine tumors (NETs) are a group of tumors that develop from neuroendocrine cells – specialized cells found throughout the body that function like a combination of nerve cells and hormone-producing cells. These tumors can appear in many organs, including the lungs, pancreas, intestines, stomach, and adrenal glands. Some neuroendocrine tumors grow slowly over many years, while others may develop more quickly. Because NETs can produce hormones, they may cause a wide range of symptoms depending on where they form and whether they release excess hormones into the bloodstream. This article explains neuroendocrine tumors in a simple, supportive way – covering symptoms, causes, diagnosis, stages, treatment, and living with the condition. The information shared here is for education only and not medical advice.

What Are Neuroendocrine Tumors?

Neuroendocrine tumors form when neuroendocrine cells start growing abnormally. These cells exist in many parts of the body and help regulate digestion, breathing, blood pressure, and metabolism. NETs can be benign (non-cancerous) or malignant (cancerous). Even slow-growing tumors may cause symptoms if they release hormones or grow large enough to press on nearby organs.

Common locations where NETs develop include:

• Gastrointestinal tract (stomach, small intestine, colon, rectum)
• Pancreas (Pancreatic NETs)
• Lungs (Pulmonary NETs)
• Appendix
• Adrenal glands
• Thyroid (medullary carcinoma)
• Thymus

Some NETs do not produce hormones (non-functioning tumors), while others release hormones that cause specific symptoms known as carcinoid syndrome. Many NETs are diagnosed late because early symptoms may be mild or confused with other conditions such as IBS, asthma, or ulcers.

Symptoms of Neuroendocrine Tumors

Symptoms depend on the tumor type, size, and hormone activity. Some tumors remain silent for years and are discovered during scans for unrelated health issues. Functioning tumors may cause hormone-related symptoms, while non-functioning tumors may only cause pressure symptoms as they grow.

General Symptoms May Include:

• Abdominal pain or discomfort
• Unexplained weight changes
• Nausea or vomiting
• Fatigue or weakness
• Loss of appetite
• Diarrhea or constipation
• Feeling of fullness after small meals

Hormone-Related Symptoms (Carcinoid Syndrome)

• Skin flushing (warmth or redness of face)
• Rapid heartbeat or palpitations
• Wheezing or breathing difficulty
• Chronic diarrhea
• Low blood pressure spells
• Carcinoid crisis (rare emergency with sudden flushing and blood pressure changes)

Carcinoid syndrome usually occurs in NETs that produce serotonin or other hormones, most commonly in gastrointestinal or lung NETs. Not all NET patients experience these symptoms – many tumors are non-functioning.

Causes & Risk Factors

The exact cause of neuroendocrine tumors is not always known. They may develop when neuroendocrine cells undergo DNA changes that cause them to grow without control. Some NETs are linked to inherited genetic conditions, while others occur spontaneously without a clear reason.

Possible risk factors include:

• Family history of NETs or endocrine tumors
• Inherited syndromes such as MEN1 (Multiple Endocrine Neoplasia type 1)
• Neurofibromatosis type 1
• Von Hippel-Lindau disease
• Tuberous sclerosis
• Age (more common in adults over 50)
• Chronic inflammation of the digestive system

Having risk factors does not mean a person will develop NETs, and many individuals diagnosed have no known risk history. Early recognition may help guide treatment and management.

Diagnosis & Tests

Because symptoms may appear slowly or resemble other conditions, diagnosis often involves multiple tests. A healthcare professional may order blood tests, imaging scans, and biopsies to confirm the diagnosis and evaluate tumor spread.

Common diagnostic tests include:

• Blood and urine tests: Check hormone levels such as serotonin and chromogranin A.
• CT or MRI scan: Shows tumor location, size, and spread.
• PET scan: Helps detect active cancer cells.
• Endoscopy or colonoscopy: Used for gastrointestinal NETs.
• Biopsy: Confirms cancer type through tissue sample.
• Octreotide scan or Ga-68 DOTATATE PET: Highly sensitive scan for NET detection.

Stages of Neuroendocrine Tumors

Staging helps determine how far a neuroendocrine tumor has grown and whether it has spread to other parts of the body. Staging is important for treatment planning and prognosis. NETs may grow slowly or more aggressively depending on type and location.

NET staging often follows TNM classification:

• T (Tumor): Size and depth of the primary tumor
• N (Nodes): Whether cancer has spread to nearby lymph nodes
• M (Metastasis): Whether cancer has spread to distant organs

General Stage Breakdown

• Stage I: Small tumor localized to its original organ
• Stage II: Larger tumor but still confined to the organ
• Stage III: Tumor spread to nearby tissues or lymph nodes
• Stage IV: Metastasis to distant organs such as liver, lungs, or bones

Neuroendocrine tumors may also be graded based on cell growth rate:

Grading System

• Grade 1 (Low-grade): Slow-growing, less aggressive
• Grade 2 (Intermediate): Moderate growth rate
• Grade 3 (High-grade): Fast-growing, more aggressive

Understanding stage and grade helps doctors decide whether surgery, medication, or advanced therapy may be most effective.

Treatment Options

Treatment for NETs depends on tumor size, location, grade, hormone activity, and spread. Some NETs grow slowly and can be monitored, while others may require active treatment. The goal is to control the tumor, reduce symptoms, manage hormones, and maintain quality of life.

Common Treatment Methods

• Surgery: Often the first option for localized NETs. Can remove tumor fully or reduce size.
• Somatostatin analogs (Octreotide/Lanreotide): Help control hormone symptoms and slow tumor growth.
• Chemotherapy: Used more often for high-grade or advanced NETs.
• Targeted therapy: Drugs that block cancer growth signals (e.g., everolimus, sunitinib).
• Peptide Receptor Radionuclide Therapy (PRRT): Delivers radioactive molecules to tumor cells for destruction.
• Radiation therapy: Used when tumors cannot be removed surgically or for pain relief.
• Immunotherapy: May help the immune system recognize and attack cancer cells in some cases.
• Hormone-blocking medications: Reduce symptoms caused by excessive hormone release.

Many patients benefit from a combination of treatments over time. Because NETs can behave differently from other cancers, care is often managed by a multidisciplinary team including oncologists, endocrinologists, and surgeons.

Prognosis & Survival Rate

The prognosis for neuroendocrine tumors varies widely. Low-grade NETs may progress slowly and allow long-term survival with proper treatment and monitoring, while high-grade or metastatic NETs may grow faster and require more aggressive therapy.

Factors that influence outlook include:

• Tumor grade and stage at diagnosis
• Primary tumor location
• Response to treatment
• Presence of metastasis
• Hormonal activity and symptom severity

Many individuals live for years with NETs through ongoing management, treatment adjustments, and supportive care. Early diagnosis and regular follow-ups can improve long-term outcomes.

Prevention & Screening

There is no single way to prevent neuroendocrine tumors, especially when they develop without clear cause. While many NETs occur randomly, early monitoring and awareness can support faster diagnosis and treatment. Individuals with a family history of genetic syndromes may benefit from screening and genetic counseling.

Helpful prevention and awareness practices include:

• Routine health checkups for overall wellness
• Discussing family history of endocrine or hormonal tumors
• Monitoring unexplained digestive or respiratory symptoms
• Healthy diet with fruits, vegetables, and whole foods
• Regular physical activity to support immune function
• Avoiding smoking and heavy alcohol consumption

For those with hereditary risks such as MEN1 or von Hippel-Lindau disease, periodic hormone level tests and imaging may be recommended by specialists.

Living with Neuroendocrine Tumors

Living with NETs can vary widely between individuals. Some people may lead a normal life with minimal symptoms, especially in slow-growing cases. Others may require ongoing treatment to manage hormones, tumor growth, or long-term symptoms. Emotional, nutritional, and social support can play a key role in quality of life.

Supportive strategies may include:

• Maintaining regular follow-up appointments
• Tracking symptoms like flushing, diarrhea, or appetite changes
• Nutritional guidance to manage digestion and weight
• Stress management techniques like deep breathing or mindfulness
• Support groups for emotional well-being
• Collaboration with a dietitian, oncologist, and endocrinologist

Some individuals may face fatigue, digestive issues, or anxiety related to diagnosis. Counseling and community support resources can help families feel less overwhelmed during treatment or follow-up care.

When to See a Doctor

It may be helpful to contact a healthcare professional if symptoms related to digestion, hormone changes, or unexplained pain persist. Neuroendocrine tumors can be difficult to detect early, so recognizing unusual symptoms over time may encourage proper evaluation.

Seek medical evaluation if:

• Persistent abdominal pain or bloating occurs
• New flushing, wheezing, or rapid heartbeat develops
• Unexplained chronic diarrhea appears
• Unintended weight loss or fatigue is present
• Lumps, swelling, or discomfort appear around the abdomen or chest
• Symptoms worsen or interfere with daily life

Even if symptoms are mild, discussing them with a healthcare provider may help identify underlying issues early.

FAQ

Q: Are all neuroendocrine tumors cancerous?

A: Some NETs are benign, but many can become malignant or spread. Monitoring and early treatment may improve outcomes.

Q: Can neuroendocrine tumors spread to other organs?

A: Yes. Advanced NETs may spread to the liver, lungs, bones, or lymph nodes. Follow-up imaging is often used to monitor metastasis.

Q: Do NETs always cause symptoms?

A: No. Some tumors remain silent for years and are found incidentally during imaging for unrelated issues.

Q: Can diet help manage NET symptoms?

A: Diet alone cannot treat NETs, but a balanced diet may help manage symptoms like diarrhea, flushing, or digestion discomfort.

Q: What is the outlook for NET patients?

A: Prognosis varies. Slow-growing tumors may be manageable long-term, while high-grade aggressive NETs require more intensive treatment.

References

• National Cancer Institute — Neuroendocrine Tumors
• American Cancer Society — NET Overview
• Endocrine Society Educational Resources
• Mayo Clinic — Neuroendocrine Tumors
• NCBI Medical Journal Sources